论文部分内容阅读
目的分析他汀类药物治疗早期糖尿病肾病的临床治疗效果。方法选取本院75例早期糖尿病肾病患者的临床资料。结果两组患者治疗后,两组患者的UAER、CRP、BUN、Scr指标均优于治疗前,差异有统计学意义(P<0.05),治疗组两组患者的UAER、CRP、BUN、Scr指标下降优于对照组指标下降,差异有统计学意义(P<0.05)。结论在常规治疗的基础上,加用他汀类药物对早期糖尿病肾病患者实施治疗,可有效降低Scr、BUN、CRP、UAER等水平,对肾脏起到保护作用,效果显著,值得在临床医学中推广使用。
Objective To analyze the clinical effect of statins on early diabetic nephropathy. Methods The clinical data of 75 patients with early diabetic nephropathy in our hospital were selected. Results After treatment, the UAER, CRP, BUN and Scr in both groups were better than those before treatment (P <0.05). The UAER, CRP, BUN and Scr in the two groups were significantly higher than those before treatment Decline better than the control group indicators decreased, the difference was statistically significant (P <0.05). Conclusion On the basis of routine treatment, adding statins to patients with early diabetic nephropathy can effectively reduce the levels of Scr, BUN, CRP and UAER, and have a protective effect on the kidney, which is worthy of promotion in clinical medicine use.